Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Deep Dive: Breast Cancer - Early Stage HER2-positive Breast Cancer: Hot Topics and Future Trends 2024

Aired live on 10 Apr 2024


ESMO Deep Dive: Breast Cancer - Early Stage HER2-positive Breast Cancer: Hot Topics and Future Trends 2024

Chair: Nadia Harbeck
Speakers: Aleix Prat, Javier Cortés, Ian Krop

(Reserved to ESMO Members)

This content is for ESMO members only.


Learning objectives:

  • To acquire a deeper understanding of the clinical course of malignant disease of breast cancer.
  • To understand biological hypotheses on classification and risk stratification, ongoing/required research in therapeutics and knowledge of use of omics technologies for biomarker-enabled precision medicine for breast cancer.
  • To develop skills and abilities for critical analysis, interpretation of research data and therapeutic strategies.
  • To become better equipped for informed, innovative thinking and engagement in ongoing or new research projects.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.